The efficacy and safety of sigle-dose oral treatment with fluconazole 150mg was evaluated in 40 patients with mean age of 26 years (range 18-42 years). At the short-term follow up of 5-9 days after treatment, 85% of patients were clinically cured or showed improvement, while 70% of patients were mycologically cured. At the long-term follow up of 4-6 weeks post-treatment, 77. 5% of patients were clinically cured or improved where as 63% of patients were determined candida-free on microscopic/culture examination. No side effects were observed by the investigator or reported by the patients in this open, non-comparative study.